Influx Healthtech Limited IPO

Apply 0
Avoid 0

Closing in

Days
Hours
Mins
Secs

Don't Miss It! Mark Your Calender Now:


Incorporated in 2020, Influx Healthtech Limited is a Mumbai-based Contract Development and Manufacturing Organization (CDMO) specializing in the manufacturing of healthcare, nutraceutical, cosmetic, ayurvedic, veterinary, and homecare products. With its state-of-the-art facilities located in Thane, Maharashtra, the company provides end-to-end third-party manufacturing services, catering to a wide range of industries with stringent quality and regulatory compliance.

Core Business & Services

a) Contract manufacturing and product development for a diverse client base.

b) Services include R&D, regulatory support, formulation, and production.

Product Range

i) Nutraceuticals: Tablets, capsules, softgels, jellies, effervescent tablets, ODFs.
ii) Cosmetics: Skincare, haircare, beard care, soaps, face masks.
iii) Ayurvedic/Herbal: External applications, liquid orals, powders.
iv) Veterinary: Products for animals like dogs, birds, cattle, goats.
v) Homecare: Floor cleaners, bathroom cleaners, phenyl, disinfectants.

Clientele

Company serves a reputed and diversified clientele in the contract development and manufacturing (CDMO) space. Its key clients include well-known names such as Bling Brands Pvt Ltd, Evoq Business Ventures LLP, HSHS Nutraceuticals Ltd, Bruder Life Science, and Bigflex Lifescience Pvt Ltd. These long-standing partnerships reflect the company’s strong reputation for delivering high-quality, customized manufacturing solutions across the nutraceutical, cosmetics, and wellness sectors.

Manufacturing Facilities 

Influx operates three certified manufacturing units in Thane, Maharashtra, covering a total area of over 36,000 sq. ft. These facilities are GMP, WHO-GMP, ISO, HACCP, Halal, and FDA approved, and equipped with modern machinery, in-house R&D, and quality control labs to produce a wide range of healthcare, cosmetic, and homecare products.

Objects of the Influx Healthtech Limited IPO:

Company proposes to utilize the Net Proceeds towards funding the following objects: 1. Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division (₹22.6 cr) 2. Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division (₹11.58 cr) 3. Purchase of Machineries for Homecare and Cosmetic Division (₹2.75 cr) 4. General Corporate Purposes

Influx Healthtech Limited IPO Details:

Open Date: Jun 18 2025
Close Date: Jun 20 2025
Total Shares: 61,00,800
Face Value: ₹ 10 Per Equity Share
Issue Type: Book Building
Issue Size: 58.57 Cr.
Lot Size: 1200 Shares
Issue Price: ₹ 91 - 96 Per Equity Share
Listing At: NSE Emerge

Promoters And Management:

1. Mr. Munir Abdul Ganee Chandniwala, Founder & Managing Director, Aged 44, is the visionary founder of Influx Healthtech Ltd. With over 22 years of industry experience, he holds a Ph.D., an MBA, and a Bachelor of Pharmacy. He also completed a Diploma in Nutrition from the U.S.-based Fab Academe. Since 2002, he has led third-party manufacturing businesses in nutraceuticals, cosmetics, and Ayurveda, establishing Influx as a trusted CDMO. He is a registered pharmacist with the Maharashtra State Pharmacy Council. 2. Mrs. Shirin Munir Ahmed Chandniwala, Whole-Time Director & Co-founder, Aged 40, brings over 12 years of experience in financial management and packaging material trading. She holds a Bachelor of Commerce degree and oversees financial planning, budgeting, and operational strategies at Influx. With hands-on expertise in managing third-party manufacturing projects across nutraceuticals, cosmetics, Ayurveda, petcare, and homecare, she plays a pivotal role in driving the company’s growth. 3. Mr. Abdul Ganee Abdul Rasul Chandniwala, Aged 73 with over two decades of experience in the pharmaceutical sector, Mr. Abdul Ganee holds a Diploma in Homeopathic and Biochemic Systems of Medicine and a certificate in Modern Pharmacology. He has been instrumental in supporting the company’s foundational growth, actively assisting his son in the development of Influx Healthcare, particularly in third-party manufacturing and product strategy.

Financials of Influx Healthtech Limited IPO:

To be updated shortly

Comparison With Peers:

To be updated shortly

Lead Manager of Influx Healthtech Limited IPO:

  1. Rarever Financial Advisors Pvt. Ltd.

Registrar of Influx Healthtech Limited IPO:

  1. Maashitla Securities Pvt. Limited

Discussion on Influx Healthtech Limited IPO:

Leave a Reply